GENECAST
PrivateLast Round
IPO Announced
Jun 28, 2024
Est. Valuation
$39.71M
Total Funding Raised
$23.44M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GENECAST is a biotechnology company that develops cancer diagnostic technology equipment designed to detect, diagnose, and treat early-stage cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GENECAST Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
GENECAST Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Jun 28, 2024 | ||||
| Strategic | Feb 23, 2023 | ||||
| Series B | Jun 8, 2020 | ||||
| Series A | May 8, 2018 | ||||
| Seed | Oct 1, 2017 |
GENECAST Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Series A |
| KDB Capital Corp | Series B |
| SparkLabs Group | Seed |
| Winvest Venture Capital | Series B, IPO |
| IBK Capital | Series A |
| CJ Investment | Series B, Series A |
| KB Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 89% MoM to 4.9K.
- Jun 8, 2020
$12M round with KB Securities and Partners Investment.
GENECAST Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GENECAST's valuation, stock price, and market status.